Item 8.01 Other Events

On January 9, 2020, Amicus Therapeutics, Inc. issued a press release announcing preliminary 2019 revenue and Galafold (migalastat) commercial updates. A copy of this press release is attached hereto as Exhibit 99.1 and is incorporated herein by reference.




Item 9.01 Financial Statements and Exhibits
(d) Exhibits:

Exhibit No.            Description
   99.1       January 8, 2020 Press Release

--------------------------------------------------------------------------------





                                 Signature Page

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

AMICUS THERAPEUTICS, INC.

Date: January 9, 2020 By: /s/ Ellen S. Rosenberg

Name: Ellen S. Rosenberg
                      Title: Chief Legal Officer and Corporate Secretary

© Edgar Online, source Glimpses